FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213125571> ?p ?o ?g. }

• W4213125571 endingPage "158" @default.
• W4213125571 startingPage "158" @default.
• W4213125571 abstract "158 Background: Early clinical responses to anti-PSMA Chimeric Antigen Receptor T cells (CARs) have been observed but much like the leukemia experience, significant toxicity from macrophage activation (MAS) has also been observed Building on our experience with a first in-human armoured CAR (TmPSMA-01) targeting PSMA (with a 41BB and CD3 endodomain) coupled with a dominant-negative TGFBR2 module, where we observed anti-tumor effects but also immune-mediated toxicity, we designed a CAR with additional armour, a PD1-CD28 switch, to overcome the immune suppressive microenvironment and further improve efficacy. We successfully built tricistronic constructs that expresses the CAR, a dnTGFBR2 module and a switch receptor for PD1 and CD28. We compared the 41BB endodomain and the CD2 domain, which has shown preliminary effects reducing cytokine release. We hypothesized that these changes would increase efficacy in immune-suppressive solid tumors while reducing excessive cytokine release and untoward immune toxicity. Methods: CAR constructs were synthesized into a self-inactivating lentiviral backbone and CAR T cells manufactured comprising a control TmPSMA-01 construct and two primary constructs: PSMA-CD2z:dnTGFBR:PD1-CD28 and PSMA-41BBz:dnTGFBR:PD1-CD28. Expression of the CAR as well as T cell markers were determined by flow cytometry, and CAR affinity for target by Lumicks. CAR activation and cytotoxicity were assessed by ELISPOT, xCelligence and Celligo standard assays. A co-culture macrophage activation system was applied to each construct to assess the potential of each construct to induce MAS-like responses. Results: A significant difference was seen in the MFI of the CAR, with the CD2 based CAR consistently ̃50% lower than the 41BB and this correlated to a faster off-rate from target cells measured by Lumicks. There was no difference in exhaustion or memory markers, and cytotoxicity across a range of E:T ratios was equivalent between the CD2 and 41BB constructs. Preliminary data indicated the CD2 endodomain preserved T cell activation but with lower cytokine release. The CD2 constructs consistently produced significantly less total IL2 and IFNg after exposure to targets, yet had similar numbers of ELISPOT positive cells for IL2 and IFNg indicating less cytokine production per kill. This also resulted in significantly less macrophage based cytokines such as IL6 and IL8 in the coculture model. Using a cell line knocked out for PDL1/2 and then reengineered for constitutive PDL1/2 expression, we demonstrated improved speed of killing in the xCelligence system dependent on the PD1:CD28 switch but no increase in cytokine release. Conclusions: A CD2 based endodomain tricistronic CAR targeting PSMA (TmPSMA-02) maintained cytotoxicity, memory profile and activation while having a significantly reduced risk of inducing macrophage activation." @default.
• W4213125571 created "2022-02-24" @default.
• W4213125571 creator A5004249526 @default.
• W4213125571 creator A5038758227 @default.
• W4213125571 creator A5039519178 @default.
• W4213125571 creator A5046994711 @default.
• W4213125571 creator A5052614142 @default.
• W4213125571 creator A5059590602 @default.
• W4213125571 creator A5069469506 @default.
• W4213125571 creator A5071131605 @default.
• W4213125571 creator A5077604840 @default.
• W4213125571 creator A5090642552 @default.
• W4213125571 date "2022-02-20" @default.
• W4213125571 modified "2023-09-29" @default.
• W4213125571 title "TmPSMA-02: A CD2 endodomain containing double armored PSMA CAR T with enhanced efficacy and lower immune toxicity." @default.
• W4213125571 doi "https://doi.org/10.1200/jco.2022.40.6_suppl.158" @default.
• W4213125571 hasPublicationYear "2022" @default.
• W4213125571 type Work @default.
• W4213125571 citedByCount "3" @default.
• W4213125571 countsByYear W42131255712023 @default.
• W4213125571 crossrefType "journal-article" @default.
• W4213125571 hasAuthorship W4213125571A5004249526 @default.
• W4213125571 hasAuthorship W4213125571A5038758227 @default.
• W4213125571 hasAuthorship W4213125571A5039519178 @default.
• W4213125571 hasAuthorship W4213125571A5046994711 @default.
• W4213125571 hasAuthorship W4213125571A5052614142 @default.
• W4213125571 hasAuthorship W4213125571A5059590602 @default.
• W4213125571 hasAuthorship W4213125571A5069469506 @default.
• W4213125571 hasAuthorship W4213125571A5071131605 @default.
• W4213125571 hasAuthorship W4213125571A5077604840 @default.
• W4213125571 hasAuthorship W4213125571A5090642552 @default.
• W4213125571 hasConcept C148125776 @default.
• W4213125571 hasConcept C203014093 @default.
• W4213125571 hasConcept C2776090121 @default.
• W4213125571 hasConcept C2778690821 @default.
• W4213125571 hasConcept C2779053233 @default.
• W4213125571 hasConcept C2780850621 @default.
• W4213125571 hasConcept C3875195 @default.
• W4213125571 hasConcept C502942594 @default.
• W4213125571 hasConcept C553184892 @default.
• W4213125571 hasConcept C71924100 @default.
• W4213125571 hasConcept C8891405 @default.
• W4213125571 hasConceptScore W4213125571C148125776 @default.
• W4213125571 hasConceptScore W4213125571C203014093 @default.
• W4213125571 hasConceptScore W4213125571C2776090121 @default.
• W4213125571 hasConceptScore W4213125571C2778690821 @default.
• W4213125571 hasConceptScore W4213125571C2779053233 @default.
• W4213125571 hasConceptScore W4213125571C2780850621 @default.
• W4213125571 hasConceptScore W4213125571C3875195 @default.
• W4213125571 hasConceptScore W4213125571C502942594 @default.
• W4213125571 hasConceptScore W4213125571C553184892 @default.
• W4213125571 hasConceptScore W4213125571C71924100 @default.
• W4213125571 hasConceptScore W4213125571C8891405 @default.
• W4213125571 hasIssue "6_suppl" @default.
• W4213125571 hasLocation W42131255711 @default.
• W4213125571 hasOpenAccess W4213125571 @default.
• W4213125571 hasPrimaryLocation W42131255711 @default.
• W4213125571 hasRelatedWork W2035598784 @default.
• W4213125571 hasRelatedWork W2054886199 @default.
• W4213125571 hasRelatedWork W2466405470 @default.
• W4213125571 hasRelatedWork W2785166134 @default.
• W4213125571 hasRelatedWork W2953853904 @default.
• W4213125571 hasRelatedWork W3016877653 @default.
• W4213125571 hasRelatedWork W3097871832 @default.
• W4213125571 hasRelatedWork W3179304775 @default.
• W4213125571 hasRelatedWork W4282977040 @default.
• W4213125571 hasRelatedWork W4313406551 @default.
• W4213125571 hasVolume "40" @default.
• W4213125571 isParatext "false" @default.
• W4213125571 isRetracted "false" @default.
• W4213125571 workType "article" @default.